Minimal residual disease detected by the PCR in chronic myeloid leukemia. Comparison of cyclophosphamide-total body irradiation and busulphan-cyclophosphamide bone marrow transplantation conditioning.
Stark
R A
RA
Richard
P
P
Devergie
A
A
Galibert
F
F
Gluckman
E
E
D000328:Adult; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D016133:Polymerase Chain Reaction; D011379:Prognosis; D012008:Recurrence; D012074:Remission Induction; D014916:Whole-Body Irradiation
D003520:Cyclophosphamide; D002066:Busulfan